Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip N Murphy

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|June 5, 2007
Assessing drug-related harmPhilip N Murphy
Journal of Psychopharmacology (Oxford, England)|April 1, 2006
Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire studyPhilip N Murphy, Michelle Wareing, John Fisk
Plos One|May 25, 2023
Polyphenol supplementation and executive functioning in overweight and obese adults at risk of cognitive impairment: A systematic review and meta-analysisSara Farag, Catherine Tsang, Philip N Murphy
Foot (Edinburgh, Scotland)|September 13, 2015
Platelet rich plasma versus corticosteroid injection for plantar fasciitis: A comparative studyKowshik Jain, Philip N Murphy, Timothy M Clough
Experimental and Clinical Psychopharmacology|October 7, 2009
The association between the negative effects attributed to ecstasy use and measures of cognition and mood among usersJohn E Fisk, Catharine Montgomery, Philip N Murphy
Psychopharmacology|January 22, 2004
Visuospatial memory impairments in users of MDMA ('ecstasy')Michelle Wareing, Philip N Murphy, John E Fisk
Health Policy (Amsterdam, Netherlands)|June 1, 2022
Virtual clinics versus face-to-face review: Is the benefit the same for new orthopaedic patients?Sarah Shammout, Rosemary Wall, Philip N Murphy, et al.
Foot (Edinburgh, Scotland)|August 3, 2013
The treatment of intractable plantar fasciitis with platelet-rich plasma injectionVishwajeet Kumar, Tim Millar, Philip N Murphy, et al.
Epilepsy & Behavior : E&B|August 13, 2005
Does alexithymia differentiate between patients with nonepileptic seizures, patients with epilepsy, and nonpatient controls?Jane Bewley, Philip N Murphy, Jenna Mallows, et al.
Human Psychopharmacology|August 18, 2006
The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?John E Fisk, Catharine Montgomery, Michelle Wareing, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|June 5, 2007
Assessing drug-related harmPhilip N Murphy
Journal of Psychopharmacology (Oxford, England)|April 1, 2006
Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire studyPhilip N Murphy, Michelle Wareing, John Fisk
Plos One|May 25, 2023
Polyphenol supplementation and executive functioning in overweight and obese adults at risk of cognitive impairment: A systematic review and meta-analysisSara Farag, Catherine Tsang, Philip N Murphy
Foot (Edinburgh, Scotland)|September 13, 2015
Platelet rich plasma versus corticosteroid injection for plantar fasciitis: A comparative studyKowshik Jain, Philip N Murphy, Timothy M Clough
Experimental and Clinical Psychopharmacology|October 7, 2009
The association between the negative effects attributed to ecstasy use and measures of cognition and mood among usersJohn E Fisk, Catharine Montgomery, Philip N Murphy
Psychopharmacology|January 22, 2004
Visuospatial memory impairments in users of MDMA ('ecstasy')Michelle Wareing, Philip N Murphy, John E Fisk
Health Policy (Amsterdam, Netherlands)|June 1, 2022
Virtual clinics versus face-to-face review: Is the benefit the same for new orthopaedic patients?Sarah Shammout, Rosemary Wall, Philip N Murphy, et al.
Foot (Edinburgh, Scotland)|August 3, 2013
The treatment of intractable plantar fasciitis with platelet-rich plasma injectionVishwajeet Kumar, Tim Millar, Philip N Murphy, et al.
Epilepsy & Behavior : E&B|August 13, 2005
Does alexithymia differentiate between patients with nonepileptic seizures, patients with epilepsy, and nonpatient controls?Jane Bewley, Philip N Murphy, Jenna Mallows, et al.
Human Psychopharmacology|August 18, 2006
The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?John E Fisk, Catharine Montgomery, Michelle Wareing, et al.
Pageof 3